What is the current price and valuation of PATH stock?

PATH stock is trading pre-market at **$11.57** on the NYSE. Trailing PE is **27.56**, price-to-sales around **3.85**, and market cap about **$6.19 billion**. These factors position PATH as a mid-valued software name with strong gross margins.

What does Meyka AI forecast for PATH stock?

Meyka AI's forecast model projects yearly **$13.83** for PATH stock, implying **19.54%** upside from **$11.57**. The model also shows a monthly view at **$10.61**. Forecasts are projections and not guarantees.

What are the main catalysts for PATH stock in 2026?

Primary catalysts include agentic AI platform adoption, enterprise ARR growth, expanded partnerships such as with Deloitte, and share buybacks. Positive surprises on retention or faster ARR expansion would likely lift PATH stock.

What are the key risks for PATH stock investors?

Key risks for PATH stock are slower full-year revenue guidance (management implied roughly **10%** growth), customer retention and adoption pacing, analyst downgrades, and continued insider selling. Execution on AI monetization is crucial.

US Stocks

Pre-market $11.57: UiPath (PATH) NYSE on 17 Mar 2026 sees AI margin gains

ByDanny Kontos March 17, 2026March 17, 2026

Pre-market we see PATH stock at $11.57 on the NYSE in the United States on 17 Mar 2026. That price tracks a 50-day average of $13.10 and a 200-day average of $13.42, while volume is elevated at 38,790,185 shares. UiPath Inc. (PATH) reported a recent quarter with EPS $0.42 and a trailing PE near 27.56, leaving investors balancing AI-driven margin gains against tempered full-year guidance.